Literature DB >> 30692862

Fatigue Can Be Objectively Measured in Multiple Sclerosis: Multipl Sklerozda Yorgunluk Objektif Olarak Ölçülebilir.

Haluk Gümüş1.   

Abstract

Multiple Sclerosis (MS), is a chronic inflammatory demyelinating disorder affecting the white matter in the central nervous system (CNS), seen usually among young adults (20-40 years of age). Fatigue is an important symptom that affects a large portion of the patient population. The reason for fatigue seen in MS patients is still not well-known. Fatigue is a subjective and non-specific symptom; therefore, it is quite difficult to evaluate fatigue. This symptom has been reported in 75-87% of patients with multiple sclerosis (MS) and two-thirds of these patients indicated fatigue as one of the worst three common symptoms they experienced. In this review, objective measurement methods of fatigue which is a subjective complaint will be discussed.

Entities:  

Keywords:  Multiple sclerosis; fatique; measurement

Year:  2018        PMID: 30692862      PMCID: PMC6278621          DOI: 10.29399/npa.23396

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  21 in total

Review 1.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Multiple sclerosis-related fatigue.

Authors:  William S MacAllister; Lauren B Krupp
Journal:  Phys Med Rehabil Clin N Am       Date:  2005-05       Impact factor: 1.784

3.  Fatigue in multiple sclerosis and its relationship to depression and neurologic disability.

Authors:  R Bakshi; Z A Shaikh; R S Miletich; D Czarnecki; J Dmochowski; K Henschel; V Janardhan; N Dubey; P R Kinkel
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

4.  Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

Authors:  M P Amato; G Ponziani; F Rossi; C L Liedl; C Stefanile; L Rossi
Journal:  Mult Scler       Date:  2001-10       Impact factor: 6.312

5.  Presentation and mortality of primary biliary cirrhosis in older patients.

Authors:  J L Newton; D E Jones; J V Metcalf; J B Park; A D Burt; M F Bassendine; O F James
Journal:  Age Ageing       Date:  2000-07       Impact factor: 10.668

6.  Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis.

Authors:  M E Morris; C Cantwell; L Vowels; K Dodd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 7.  Treatments for fatigue in multiple sclerosis: a rapid and systematic review.

Authors:  P Brañas; R Jordan; A Fry-Smith; A Burls; C Hyde
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

Review 8.  Fatigue in multiple sclerosis: current understanding and future directions.

Authors:  Steven R Schwid; Melissa Covington; Benjamin M Segal; Andrew D Goodman
Journal:  J Rehabil Res Dev       Date:  2002 Mar-Apr

Review 9.  The assessment of fatigue: a practical guide for clinicians and researchers.

Authors:  A J Dittner; S C Wessely; R G Brown
Journal:  J Psychosom Res       Date:  2004-02       Impact factor: 3.006

10.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

View more
  1 in total

Review 1.  New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis.

Authors:  Ewa Zielińska-Nowak; Lidia Włodarczyk; Joanna Kostka; Elżbieta Miller
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.